{
    "nctId": "NCT04031885",
    "briefTitle": "A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer",
    "officialTitle": "A Multicenter, Open-Label, Randomized-Controlled Study of Abemaciclib, a CDK4 and 6 Inhibitor, in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer With Visceral Metastases",
    "overallStatus": "TERMINATED",
    "conditions": "Metastatic Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 4,
    "primaryOutcomeMeasure": "Objective Response Rate (ORR): Percentage of Participants Who Achieve Complete Response (CR) or Partial Response (PR)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Participants must be females of post-menopausal status with HR+, HER2- breast cancer that has spread to internal organs\n* Participants must have had at least one endocrine therapy\n* Participants must be willing to use a device to answer daily questions about how they are doing for the duration of their participation in the study\n* If participant has diarrhea from a previous treatment, they should talk to their doctor to ensure they have recovered enough to participate in this study\n\nExclusion Criteria:\n\n* Participants must not have breast cancer that has spread to the brain if untreated and with symptoms\n* Participants must not have had any systemic treatment after their breast cancer has spread unless it is endocrine therapy\n* Participants must not have certain active infections including HIV or hepatitis\n* Participants must not be pregnant or breastfeeding\n* Participants must not have certain types of cancers or certain previous cancer treatments\n* Participants must not have certain serious medical conditions, including heart or lung disease, or have had certain types of tissue or organ transplants",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}